Patent Portfolio
Prophylactic drug/therapeutic drug for progressive supranuclear palsy
| Ref. No. | AJ298 |
|---|---|
| Appl. No. （filing date） |
PCT/JP2024/011319（2024/3/22） |
| Pub. No. （Pub. date） |
WO2024/195858（2024/9/26） |
| Priority claim No. （Priority date） |
JP 2023-046944（2023/03/23） |
| Patent No. | - |
| Inventor | INOUE Haruhisa, et al. |
| Assignee | Kyoto University / Taisho Pharmaceutical Co., Ltd. |
| Title of Invention | Prophylactic drug/therapeutic drug for progressive supranuclear palsy |
| Abstract | The invention relates to a preventive and/or therapeutic agent for progressive supranuclear palsy (hereinafter, sometimes referred to as PSP). More specifically, it relates to a preventive and/or therapeutic agent for neurodegenerative diseases including PSP, which contains as an active ingredient a growth arrest and DNA damage-inducible protein 34 (hereinafter, sometimes referred to as GADD34; also known as protein phosphatase 1 regulatory subunit 15A; hereinafter, sometimes referred to as PPP1R15A, and GADD34 and PPP1R15A may be referred to together) inhibitor, such as guanabenz. |
| Comments |
This invention is expected that small molecule compounds will be used in the treatment of progressive supranuclear palsy. |
| Information (External link) |
https://www.j-platpat.inpit.go.jp/c1801/PU/WO-A-2024-195858/50/en |
| Tag | Nerve (Neuron) |